Morgan Stanley »

Aclaris Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $12M 1.7M 6.85
2023-06-30 $17M 1.6M 10.37
2022-12-31 $2.2M 140k 15.74
2022-06-30 $2.5M 161k 15.24
2022-03-31 $531k 31k 17.17
2021-06-30 $412k 23k 17.65
2020-12-31 $119k 18k 6.51
2020-09-30 $52k 20k 2.59
2020-06-30 $22k 14k 1.65
2020-03-31 $3.2k 3.8k 0.84
2019-12-31 $4.8M 2.5M 1.89
2019-09-30 $1.8M 1.7M 1.06
2019-03-31 $1.2M 207k 5.99
2018-12-31 $1.2M 167k 7.39
2018-09-30 $5.6M 384k 14.52
2018-06-30 $1.3M 66k 19.97
2018-03-31 $2.0M 117k 17.52
2017-12-31 $4.6M 188k 24.67
2017-03-31 $583k 20k 29.83
2016-12-31 $1.6M 59k 27.13
2016-09-30 $689k 27k 25.56
2016-06-30 $2.0k 114 17.54
2015-12-31 $11k 391 28.13